Dallas Flies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Editorial Article: Accelerated production of novel immunotherapies with high-throughput screening Dr. Dallas Flies, Vice President, Discovery Research, NextCure, Inc. discusses the cutting-edge technology transforming the identification of new targets for the development of effective immunotherapeutics 29 Jul 2021 Dr. Dallas Flies, Vice President, Discovery Research, NextCure, Inc. A major challenge in the development and production of immunotherapeutics is the shortage of novel targets that can be exploited. To tackle this, NextCure, a fully integrated clinical-stage biopharmaceutical company, is working hard to accelerate the development of cancer therapeutics and improve patient care, by identifying potential targets through advanced high-throughput screening techniques such as flow cytometry and cell sorting.

United statesDiscovery researchDiscovery research at nextcureDiscovery research departmentNextcure incEditorial articleDallas fliesVice presidentCell sorterIntegrated nextcure discoveryImmune oncologyCell sortersஒன்றுபட்டது மாநிலங்களில்கண்டுபிடிப்பு ஆராய்ச்சிகண்டுபிடிப்பு ஆராய்ச்சி துறைதலையங்கம் கட்டுரை